Peptide record

TPDB11461

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
33 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11461
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb
standard
No
A 33-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLLDTFKNMAINAAHGAGVSVLNALSCKLKKTC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C147H250N42O43S3
REQPWY
AL
3390.04
9.72
5
1
15
+3
0.31
0.412
103.64
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.04
9
Residue Composition
number
5
A
0
R
3
N
1
D
2
C
0
E
0
Q
3
G
1
H
1
I
5
L
4
K
1
M
1
F
0
P
2
S
2
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 5 R: 0 N: 3 D: 1 C: 2 E: 0 Q: 0 G: 3 H: 1 I: 1 L: 5 K: 4 M: 1 F: 1 P: 0 S: 2 T: 2 W: 0 Y: 0 V: 2
Chemical Descriptors
33 reviewed residue count
C147H250N42O43S3 sequence-only estimate (linear, free termini)
3390.04 sequence-only estimate (linear, free termini)
9.72 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
0.31 sequence-only estimate (linear, free termini)
0.412 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E. coli (MIC 6.3 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 2 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

MIC 6.3 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC 6.3 ug/ml), and yeast C. albicans (MIC 3.2 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
3.2 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

lled P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC 6.3 ug/ml), and yeast C. albicans (MIC 3.2 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E. coli (MIC 6.3 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 5 Activity

Activity

MIC
Antifungal
6.3 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 6.3 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC 6.3 ug/ml), and yeast C. albicans (MIC 3.2 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
3.2 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

lled P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC 6.3 ug/ml), and yeast C. albicans (MIC 3.2 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E. coli (MIC 6.3 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 8 Activity

Activity

MIC
Antiparasitic
6.3 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 6.3 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC 6.3 ug/ml), and yeast C. albicans (MIC 3.2 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
3.2 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

lled P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC 6.3 ug/ml), and yeast C. albicans (MIC 3.2 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
6.3 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E. coli (MIC 6.3 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 11 Activity

Activity

MIC
Antiviral
6.3 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 6.3 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC 6.3 ug/ml), and yeast C. albicans (MIC 3.2 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
3.2 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

lled P. aeruginosa) (MIC 12.6 ug/ml), Gram+ bacteria S. aureus (MIC 6.3 ug/ml), and yeast C. albicans (MIC 3.2 ug/ml). Updated 7/2021